The Medical Advisor

Incretin mimetics have transformed obesity and metabolic medicine. What began with GLP-1 receptor agonists has rapidly expanded into dual- and triple-receptor medicines designed to target appetite, glucose regulation, energy balance and body weight through several hormonal pathways at once. This guide explains what incretin mimetics are, how GLP-1 drugs work, why GIP/GLP-1 combinations can produce greater weight loss, what triple agonists are, how much weight loss has been demonstrated in clinical trials, and what the next generation of obesity medicines may look like. 2026 update: The incretin field has moved beyond injectable GLP-1 drugs. In the United States, the FDA approved oral orforglipron (Foundayo) in April 2026 for chronic weight management, while retatrutide , a GIP/GLP-1/glucagon triple agonist, has produced large weight reductions in Phase 3 trials but remains investigational and is not yet FDA-approved. What Are Incretin Mimetics? Incretin mimetics are med...

Series Hub · Living Review · September 2026 What already has trials, guidelines, or large human datasets — and what that does not authorize. Aspirin in PI3K-altered colorectal cancer is now guideline medicine. Metformin and statins are mixed. GLP-1 receptor agonists are the 2026 observational wave. This hub exists so “repurposed” stops meaning one bucket. Read this first. OneDayMD pages in this series are educational syntheses for patients, caregivers, and clinicians. They are not personal medical advice, not a protocol to self-start, and not a substitute for the treating oncologist. Off-label use, when discussed, is described so it can be raised inside a supervised relationship — not so it can replace one. Evidence badges are defined below. Observational signals can be large and still be wrong. On this page Three doors Why this series exists Evidence badges The ranked stack Part A — High-evidence agents Part B — GLP-1 / incretin oncology GLP-1 hold / continue fl...

Medical reviewed | Last updated on June 30, 2026. Introduction With 2025's and 2026's,  700+ anecdotal cases compilations , we're incorporating fresh head-to-head insights. These benzimidazoles—microtubule disruptors and metabolic saboteurs—offer hope for aggressive cancers, but evidence remains preclinical/case-based.  Disclaimer: Not FDA/EMA-approved for cancer; off-label use requires physician oversight (monitor LFTs). Enroll in trials like NCT05318469. We're informing, not personal medical advise—consult pros. What is Fenbendazole used for in humans?  Fenbendazole (also known as fenben) is a veterinary medication used to treat parasites and worms such as tapeworms, hookworms, roundworms, and whipworms, in animals. It is commonly used under brand names like Panacur C and Safe-Guard. If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard ab...